Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 13/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.64 |
| ▸ | MEN1 | O00255 | 8/20 | 0.64 |
| ▸ | POLB | P06746 | 7/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | GSK3B | P49841 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 7/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.58 |
| ▸ | GAA | P10253 | 3/20 | 0.58 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | PKM | P14618 | 3/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12999422 | 0.84 | GSK3B (0.69) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL31358849 | 0.84 | GSK3B (0.66) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL31358819 | 0.84 | GSK3B (0.58) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL31358665 | 0.84 | KMT2A (0.73) | MAPTKMT2AMEN1POLBGSK3B | |
| SCHEMBL31358780 | 0.83 | KMT2A (0.57) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL31358744 | 0.83 | KMT2A (0.57) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL31358680 | 0.83 | KMT2A (0.58) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL3769626 | 0.82 | GSK3B (0.72) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL31358800 | 0.82 | KMT2A (0.60) | MAPTKMT2AMEN1POLBCYP1A2 | |
| SCHEMBL31358851 | 0.80 | KMT2A (0.59) | MAPTKMT2AMEN1POLBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250026741-A1 | INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute | 2025-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250026741-A1 | INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF | PTPN18, PTPN7, PTPN1 | MAPT 4688/4885KMT2A 1043/4885MEN1 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.